Capital Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Capital Bank & Trust's BMY Position: Q2 2021 in Review
Capital Bank & Trust sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 32,841 shares — an estimated $2.07M sold.
Capital Bank & Trust first reported a position in BMY in Q2 2017 and held it in 16 quarters. The position peaked at $2.07M in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Capital Bank & Trust reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Capital Bank & Trust sold 32,841 Bristol-Myers Squibb shares in Q2 2021, an estimated $2.07M.
- Capital Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 16 quarters.
- Capital Bank & Trust's Bristol-Myers Squibb position peaked at $2.07M in Q1 2021.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Capital Bank & Trust's 13F filing for Q2 2021, filed 16 Aug 2021.